Overgrowth

1. Ashcraft MW , Hartzband PI , Van Herle AJ , et al. A unique growth factor in patients with acromegaloidism. J Clin Endocrinol Metab. 1983;57:272-276.

2. Iwatani N , Kodama M , Miike T . Endocrinological evaluation of GH deficient patient with acromegaloidism showing excessive growth. Endocrinol Jpn. 1992;39:59-64.

3. Yamane Y , Okamoto S , Fukui H , et al. 48, XXYY syndrome associated with acromegaloidism. Intern Med. 1993; 32:160-165.

4. Schlesinger S , MacGillivray MH , Munschauer RW . Acceleration of growth and bone maturation in childhood thyrotoxicosis.JPediatr. 1973;83:233-236.

5. Berardinelli W . An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab. 1954;14:193-204.

6. Seip M . Lipodystrophy and gigantism with associated endocrine manifestations. Acta Paediatr. 1959;48:555-574.

7. BrunzellJD , Shankle SW , BethuneJE . Congenital generalized lipodystrophy accompanied by cystic angiomatosis. Ann Intern Med. 1968;69:501-516.

8. Huseman C , Johanson A , Varma M , Blizzard RM . Congenital lipodystrophy: an endocrine study in three siblings. I. Disorders of carbohydrate metabolism.JPediatr. 1978;93:221-226.

9. Mabry CC , Hollingsworth DR , Upton GV , Corbin A . Pituitary-hypothalamic dysfunction in generalized lipodystro-phy.JPediatr. 1973;82:625-633.

10. Soler NG , Wortsman J , Chopra IJ . Lipoatrophic diabetes: endocrine dysfunction and the response to control hypertriglyceridemia. Metabolism: Clinical & Experimental. 1982;31:19-24.

11. Berge T , Brun A , Hansing B , Kjellman B . Congenital generalized lipodystrophy. Report on one case, with special reference to postmortem findings. Acta Pathologica et Microbiologica Scan-dinavica-Section A, Pathology. 1976; 84:47-54.

12. van der Vorm ER , Kuipers A , Bonenkamp JW , et al. Patients with lipodystrophic diabetes mellitus of the Seip-Berardinelli type, express normal insulin receptors. Diabetologia. 1993;36:172-174.

13. Wachslicht-Rodbard H , Muggeo M , Kahn CR , et al. Heterogeneity of the insulin-receptor interaction in lipoatrophic diabetes. J Clin Endocrinol Metab. 1981;52:416-425.

14. Considine RV , Sinha MK , Heiman ML , Kriauciunas A , Stephens TW , Nyce MR , et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N EnglJ Med. 1996;334:292-295.

15. Lawrence RD . Lipodystrophy and hepatomegaly with diabetes, lipaemia and other metabolic disturbance: a case throwing new light on the action of insulin. Lancet. 1946;1:724-731.

16. Russell A . A diencephalic syndrome of emaciation in infancy and childhood. Arch Dis Child. 1951;26:274-274.

17. Goldstein BJ . Syndromes of extreme insulin resistance. In: Kahn CR , Weir GC , eds. Joslin 's Diabetes Mellitus, 13th ed. Philadelphia: Lea & Febiger; 1994:282-299.

18. Rosen BS , Cook KS , Yaglom J , et al. Adipsin and complement factor D activity: an immune-related defect in obesity. Science. 1989;244:1483-1487.

19. Flier JS , Cook KS , Usher P , Spiegelman BM . Severely impaired adipsin expression in genetic and acquired obesity. Science. 1987;237:405-408.

20. McLean RH , Hoefnagel D . Partial lipodystrophy and familial C3 deficiency. Hum Hered. 1980;30:149-154.

21. KobberlingJ , Dunnigan MG . Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J Med Genet. 1986;23:120-127.

22. Burn J , Baraitser M . Partial lipoatrophy with insulin resistant diabetes and hyperlipidaemia (Dunnigan syndrome). JMed Genet. 1986;23:128-130.

23. Freidenberg GR , Cutler DL , Jones MC , et al. Severe insulin resistance and diabetes mellitus in mandibu-loacral dysplasia. AmJDis Child. 1992; 146:93-99.

24. Kaplan SL , Grumbach MM . Clinical review 14: pathophysiology and treatment of sexual precocity. J Clin Endocrinol Metab. 1990;71:785-789.

25. Grave GL , Cutler GB Jr. Sexual Precocity-Etiology, Diagnosis, and Management. New York: Raven Press; 1993.

26. Ibanez L , Virdis R , Potau N , et al. Natural history of premature pubarche: an auxological study. J Clin Endocrinol Metab. 1992;74:254-257.

27. MillsJL , Stolley PD , DaviesJ , Moshang T Jr . Premature thelarche. Natural history and etiologic investigation. AmJ Dis Child. 1981;135:743-745.

28. Testoderm ®. Physicians' Desk Reference, 49th ed. Montvale, NJ: Medical Economics Data; 1996:499-499.

29. Androderm ®. Pharmaceutical Product-Prescribing Information. Smith-Kline Beecham, Dec. 1995.

30. Smith EP , Boyd J , Frank GR , et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. NEnglJMed. 1994;331:1056-1061.

31. Morishima A , Grumbach MM , Simpson ER , et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995;80:3689-3689.

32. Conte FA , Grumbach MM , Ito Y , et al. A syndrome of female pseudoher-maphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450-arom). J Clin Endocrinol Metab. 1994; 78:1287-1292.

33. Shozu M , Akasofu K , Harada T , Kubota Y A new cause of female pseudo-hermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab. 1991;72:560-566.

34. Ito Y , Fisher CR , Conte FA , et al. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Nat Acad Sci USA. 1993;90:11673-11677.

35. Bulun SE . Aromatase deficiency in women and men: would you have predicted the phenotypes? J Clin Endocrinol Metab. 1996;81:867-871.